Association between TNF-α - 308 G/A polymorphism and COPD susceptibility: A meta-analysis update

International Journal of COPD

Volumn 11, Issue 1, 2016, Pages 1367-1379

  Zhang, Lu ^a   Gu, Hao ^a   Gu, Yihang ^a   Zeng, Xiaoning ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

COPD; Cytokine; Ethnicity; Genotype; Smokers

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR;

ALLELE; ASIAN; CASE CONTROL STUDY; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE PREDISPOSITION; ETHNIC DIFFERENCE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; PATHOGENESIS; POLYMERASE CHAIN REACTION; REAL TIME POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVIEW; RISK ASSESSMENT; SENSITIVITY ANALYSIS; SEQUENCE ANALYSIS; SMOKING; SYSTEMATIC ERROR; SYSTEMATIC REVIEW; TNFALPHA GENE; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MODEL; ETHNOLOGY; GENE FREQUENCY; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETICS; HETEROZYGOTE; HOMOZYGOTE; META ANALYSIS; ODDS RATIO; PATHOPHYSIOLOGY; PHENOTYPE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTOR;

ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; MODELS, GENETIC; ODDS RATIO; PHENOTYPE; POLYMORPHISM, GENETIC; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK ASSESSMENT; RISK FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84975828046     PISSN: 11769106     EISSN: 11782005     Source Type: Journal    
DOI: 10.2147/COPD.S105394     Document Type: Review

References (69)

1. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007;176(6):532-555.
2. Pauwels RA, Rabe KF. Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet. 2004;364(9434):613-620.
3. Fang X, Wang X, Bai C. COPD in China: the burden and importance of proper management. Chest. 2011;139(4):920-929.
4. Lokke A, Lange P, Scharling H, Fabricius P, Vestbo J. Developing COPD: a 25 year follow up study of the general population. Thorax. 2006;61(11):935-939.
5. Bascom R. Differential susceptibility to tobacco smoke: possible mechanisms. Pharmacogenetics. 1991;1(2):102-106.
6. Silverman EK, Chapman HA, Drazen JM, et al. Genetic epidemiology of severe, early-onset chronic obstructive pulmonary disease. Risk to relatives for airflow obstruction and chronic bronchitis. Am J Respir Crit Care Med. 1998;157:1770-1778.
7. Sandford AJ, Joos L, Pare PD. Genetic risk factors for chronic obstructive pulmonary disease. Curr Opin Pulm Med. 2002;8(2):87-94.
8. Keatings VM, Collins PD, Scott DM, Barnes PJ. Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med. 1996;153(2):530-534.
9. Mueller R, Chanez P, Campbell AM, Bousquet J, Heusser C. Different cytokine patterns in bronchial biopsies in asthma and chronic bronchitis. Respir Med. 1996;90(2):79-85.
10. Sun G, Stacey MA, Vittori E, Marini M, Bellini A, Kleimberg J. Cellular and molecular characteristics of inflammation in chronic bronchitis. Eur J Clin Invest. 1998;28(5):364-372.
11. Brogger J, Steen VM, Eiken HG, Gulsvik A, Bakke P. Genetic association between COPD and polymorphisms in TNF, ADRB2 and EPHX1. Eur Respir J. 2006;27(4):682-688.
12. Papatheodorou A, Latsi P, Vrettou C, Dimakou A, Chroneou A, Makrythanasis P. Development of a novel microarray methodology for the study of SNPs in the promoter region of the TNF-alpha gene: their association with obstructive pulmonary disease in Greek patients. Clin Biochem. 2007;40(12):843-850.
13. Trajkov D, Mirkovska-Stojkovikj J, Petlichkovski A, Strezova A, Efinska-Mladenovska O, Sandevska E. Association of cytokine gene polymorphisms with chronic obstructive pulmonary disease in Macedonians. Iran J Allergy Asthma Immunol. 2009;8(1):31-42.
14. Cordoba-Lanus E, Baz-Davila R, de-Torres JP, Rodriguez-Perez MC, Maca-Meyer N, Varo N. TNFA-863 polymorphism is associated with a reduced risk of chronic obstructive pulmonary disease: a replication study. BMC Med Genet. 2011;12:132.
15. Wilson AG, di Giovine FS, Blakemore AI, Duff GW. Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by NcoI restriction of PCR product. Hum Mol Genet. 1992;1(5):353.
16. Huang SL, Su CH, Chang SC. Tumor necrosis factor-alpha gene polymorphism in chronic bronchitis. Am J Respir Crit Care Med. 1997;156(5):1436-1439.
17. Sakao S, Tatsumi K, Igari H, Shino Y, Shirasawa H, Kuriyama T. Association of tumor necrosis factor alpha gene promoter polymorphism with the presence of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001;163(2):420-422.
18. Gingo MR, Silveira LJ, Miller YE, Friedlander AL, Cosgrove SP, Chan ED. Tumour necrosis factor gene polymorphisms are associated with COPD. Eur Respir J. 2008;31(5):1005-1012.
19. Chierakul N, Wongwisutikul P, Vejbaesya S, Chotvilaiwan K. Tumor necrosis factor-alpha gene promoter polymorphism is not associated with smoking-related COPD in Thailand. Respirology. 2005;10(1):36-39.
20. Ezzeldin N, Shalaby A, Saad-Hussein A, Ezzeldin H, El Lebedy D, Farouk H. Association of TNF-alpha-308G/A, SP-B 1580 C/T, IL-13-1055 C/T gene polymorphisms and latent adenoviral infection with chronic obstructive pulmonary disease in an Egyptian population. Arch Med Sci. 2012;8(2):286-295.
21. Teramoto S, Ishii T, Ishii M, Yamamoto H, Yamaguchi Y, Hibi S. Variation in the tumour necrosis factor-alpha gene is not associated with susceptibility to Asian COPD. Eur Respir J. 2008;31(3):682-683.
22. Higham MA, Pride NB, Alikhan A, Morrell NW. Tumour necrosis factor-alpha gene promoter polymorphism in chronic obstructive pulmonary disease. Eur Respir J. 2000;15(2):281-284.
23. Chappell S, Daly L, Morgan K, Baranes TG, Roca J, Rabinovich R. Variation in the tumour necrosis factor gene is not associated with susceptibility to COPD. Eur Respir J. 2007;30(4):810-812.
24. Seifart C, Dempfle A, Plagens A, Seifart U, Clostermann U, Muller B. TNF-alpha-, TNF-beta-, IL-6-, and IL-10-promoter polymorphisms in patients with chronic obstructive pulmonary disease. Tissue Antigens. 2005;65(1):93-100.
25. Tanaka G, Sandford AJ, Burkett K, Connett JE, Anthonisen NR, Pare PD. Tumour necrosis factor and lymphotoxin A polymorphisms and lung function in smokers. Eur Respir J. 2007;29(1):34-41.
26. Castaldi PJ, Cho MH, Cohn M, Langerman F, Moran S, Tarragona N. The COPD genetic association compendium: a comprehensive online database of COPD genetic associations. Hum Mol Genet. 2010;19(3):526-534.
27. Smolonska J, Wijmenga C, Postma DS, Boezen HM. Meta-analyses on suspected chronic obstructive pulmonary disease genes: a summary of 20 years' research. Am J Respir Crit Care Med. 2009;180(7):618-631.
28. Zhan P, Wang J, Wei SZ, Qian Q, Qiu X, Yu LK. TNF-308 gene polymorphism is associated with COPD risk among Asians: meta-analysis of data for 6, 118 subjects. Mol Biol Rep. 2010;38(1):219-227.
29. Zhang S, Wang C, Xi B, Li X. Association between the tumour necrosis factor-alpha-308G/A polymorphism and chronic obstructive pulmonary disease: an update. Respirology. 2011;16(1):107-115.
30. Li Y, Guo B, Zhang L, Han J, Wu B, Xiong H. Association between C-589T polymorphisms of interleukin-4 gene promoter and asthma: a metaanalysis. Respir Med. 2008;102(7):984-992.
31. Sagoo GS, Julian L, Higgins JPT. Systematic reviews of genetic association studies. PLoS Med. 2009;6(3):e1000028.
32. Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603-605.
33. Thakkinstian A, McElduff P, D'Este C, Duffy D, Attia J. A method for meta-analysis of molecular association studies. Stat Med. 2005;24(9):1291-1306.
34. Ishii T, Matsuse T, Teramoto S, et al. Neither IL-1beta, IL-1 receptor antagonist, nor TNF-alpha polymorphisms are associated with susceptibility to COPD. Respir Med. 2000;94(9):847-851.
35. Keatings VM, Cave SJ, Henry MJ, Morgan K, O'Connor CM, FitzGerald MX. A polymorphism in the tumor necrosis factor-alpha gene promoter region may predispose to a poor prognosis in COPD. Chest. 2000;118(4):971-975.
36. Shi YZ, Wang XJ, Sun HM. Detection of TNF-a gene polymorphism in COPD patients. Basic Med Sci Clin. 2000;20:95.
37. Kucukaycan M, Van Krugten M, Pennings HJ, et al. Tumor necrosis factor-alpha +489G/A gene polymorphism is associated with chronic obstructive pulmonary disease. Respir Res. 2002;3:29.
38. Ferrarotti I, Zorzetto M, Beccaria M, et al. Tumour necrosis factor family genes in a phenotype of COPD associated with emphysema. Eur Respir J. 2003;21(3):444-449.
39. He B, Jiang L, Ning L. Tumor necrosis factor-a gene 308 A allele can predispose to chronic obstructive pulmonary disease in smokers. Chin J Respir Crit Care Med. 2003;12:226-229.
40. Ma Z, Zhang Z, Han Z. A study on relationship between tumor necrosis factor alpha gene promoter polymorphism and susceptibility to development of COPD. Pract Prev Med. 2004;11(5):417-419.
41. Broekhuizen R, Grimble RF, Howell WM, et al. Pulmonary cachexia, systemic inflammatory profile, and the interleukin 1beta-511 single nucleotide polymorphism. Am J Clin Nutr. 2005;82(5):1059-1064.
42. Hegab AE, Sakamoto T, Saitoh W, et al. Polymorphisms of TNFalpha, IL1beta, and IL1RN genes in chronic obstructive pulmonary disease. Biochem Biophys Res Commun. 2005;329(4):1246-1252.
43. Ma Z, Zhang Z, Han Z. A study on the relationship between tumor necrosis factor a gene promoter polymorphism and the expressive levels of TNF-a protein. J Clin Intern Med. 2005;22(4):230-232.
44. Jiang L, He B, Zhao MW, Ning LD, Li XY, Yao WZ. Association of gene polymorphisms of tumour necrosis factor-alpha and interleukin-13 with chronic obstructive pulmonary disease in Han nationality in Beijing. Chin Med J. 2005;118(7):541-547.
45. Li Y, Zhai FZ, Du Y. Relationship of genetic polymorphisms of human betadefensin-1, tumor necrosis factor-alpha, mEH with chronic obstructive pulmonary disease. J Intern Med. 2006;45(3):225-226.
46. Jiang P, Li Y. Association among genetic polymorphisms of HO-1, TNF-alpha and chronic obstructive pulmonary disease. J Shandong Univ (Health Sci). 2006;44(2):1253-1257.
47. Shi YZ, Liu B, Zhang W; Study of the relationship between COPD and TNF-alpha gene polymorphism in Heilongjiang region. Chin J Tuberc Respir Dis. 2007;30:233-234.
48. Zhang Y, Wang W, Xu SH. Association between polymorphism in the gene coding for tumor necrosis factor-alpha and chronic obstructive pulmonary disease. J Taishan Med Coll. 2007;28:106-109.
49. Du Y, Sun HM, Li Y. The relationship between genetic polymorphism of tumor necrosis factor-alpha, human beta-defensin-1 and the development of chronic obstructive pulmonary disease. Clin Med J China. 2008;15:329-331.
50. Gong Y, Jin ML, Ren T. Association of tumor necrosis factor gene promoter polymorphism with chronic obstructive pulmonary disease. Clin Med J China. 2008;15:166-169.
51. Hsieh MH, Chong IW, Hwang JJ, Lee CH, Ho CK, Yu ML. Lack of associations between several polymorphisms in cytokine genes and the risk of chronic obstructive pulmonary diseases in Taiwan. Kaohsiung J Med Sci. 2008;24(3):126-137.
52. Li Y, Du Y, Jiang P. Relationship of genetic polymorphisms of heme oxygenase-1, tumor necrosis factor-alpha, human betadefensin-1 with chronic obstructive pulmonary disease. Chin J Geriatr. 2008;27:333-336.
53. Tang MQ, Mo HW, Cheng YQ. The relationship between the gene polymorphisms of TNF alpha and the genetic susceptibility to chronic obstructive pulmonary disease (COPD) with tuberculosis. J Qiqihar Med Coll. 2008;29:2949-2951.
54. Zhang YQ, Xiong JL. Correlation of genetic polymorphisms of TNF-alpha and chronic obstructive pulmonary disease in North Chinese Han people. Clin Med China. 2008;24:129-130.
55. Stankovic MM, Nestorovic AR, Tomovic AM, et al. TNF-alpha-308 promotor polymorphism in patients with chronic obstructive pulmonary disease and lung cancer. Neoplasma. 2009;56(4):348-352.
56. Chen YC, Liu SF, Chin CH, et al. Association of tumor necrosis factor-alpha-863C/A gene polymorphism with chronic obstructive pulmonary disease. Lung. 2010;188(4):339-347.
57. Yao ZG, Wang HY, Jia N; Study on the relationship between TNF-α+308, TNF-α+489 gene polymorphism and chronic obstructive pulmonary disease. Mod J Integr Trad Chin Western Med. 2012;21(22):2400-2405.
58. Shukla RK, Kant S, Bhattacharya S, Mittal B. Association of cytokine gene polymorphisms in patients with chronic obstructive pulmonary disease. Oman Med J. 2012;27(4):285-290.
59. Wang FE, Ling M. Relationship between tumor necrosis factor-α gene-308 promoter polymorphism and the susceptibility to chronic obstructive pulmonary disease in Xinjiang Uighur population. J Pract Med. 2013;29(22):3686-3689.
60. Yang L, Li F, Yan M, Li X. Association of the CYP1A1 MspI and TNFα-308 polymorphisms with chronic obstructive pulmonary disease in Inner Mongolia. Genet Mol Res. 2014;13(2):3209-3217.
61. Ozdogan N, Tutar N, Demir R, Saatci C, Kanbay A, Buyukoglan H. [Is TNF-alpha gene polymorphism related to pulmonary functions and prognosis as determined by FEV1, BMI, COPD exacerbation and hospitalization in patients with smoking-related COPD in a Turkish population?]. Rev Port Pneumol. 2014;20(6):305-310. Portuguese.
62. Chiang CH, Chuang CH, Liu SL. Transforming growth factor-beta1 and tumor necrosis factor-alpha are associated with clinical severity and airflow limitation of COPD in an additive manner. Lung. 2014;192(1):95-102.
63. Wu SM, Wang FE, Ling M. Relationship between tumor necrosis factor-α gene promoter polymorphism and susceptibility to development of COPD in Xinjiang Kazakh population. J Xi'an Jiao Tong Univ. 2014;35(6):820-823.
64. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med. 2001;163(5):1256-1276.
65. COPD Branch in Chinese Thoracic Society. The guideline of diagnosis and management for COPD. COPD Branch in Chinese Thoracic Society. Chin J Tuberc Respir Dis. 2002;25:453-460.
66. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Thoracic Society. Am J Respir Crit Care Med. 1995;152(5 Pt 2):S77-S121.
67. The guideline of diagnosis and management for COPD. Chinese Thoracic Society. Chin J Tuberc Respir Dis. 1997;20:199-233.
68. Chinese Thoracic Society. BTS guidelines for the management of chronic obstructive pulmonary disease. The COPD Guidelines Group of the Standards of Care Committee of the BTS. Thorax. 1997;52 Suppl 5:S1-S28.
69. Tanni SE, Pelegrino NR, Angeleli AY, Correa C, Godoy I. Smoking status and tumor necrosis factor-alpha mediated systemic inflammation in COPD patients. J Inflamm (Lond). 2010;7:29.